The Association of Angiotensin-Converting Enzyme 2 Polymorphism and SARS-CoV-2 Infection in the Iraqi Population.
Angiotensin-Converting Enzyme 2
Polymorphism
SARS-CoV-2
Journal
Archives of Razi Institute
ISSN: 2008-9872
Titre abrégé: Arch Razi Inst
Pays: Iran
ID NLM: 101549567
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
16
05
2022
accepted:
07
06
2022
medline:
15
6
2023
pubmed:
14
6
2023
entrez:
14
6
2023
Statut:
epublish
Résumé
The quick and advancing prevalence of the new coronavirus SARS-CoV-2 produced a global crisis surge with a profound impact on human health and worldwide economic constancy. The virus is known as one strain of coronavirus, which causes the respiratory infection responsible for the current pandemic of COVID-19. The virus spike protein has a high binding affinity to human ACE2, depending on crystallization analysis and biochemical interaction studies. Studies consistently reveal that rs2285666, a polymorphism found in ACE2, diverse significantly between Europeans and Asians, changing ACE2 expression. The alternating allele TT of rs2285666 SNP increased gene expression to 50%; thus, it may have a role in SARS-COV-2 infection vulnerability. This study aimed to investigate rs2285666 SNP association with SARS-CoV2 infection as a first report in the Iraqi population. Fifty (20 Male/30 Female) Covid-19 patients with severe symptoms with mean age (of 41.5±10.7) and 50 (20 Male/30 Female) healthy people as a control group with mean age (of 41.5±10.7) were included in this study. Sample of a patient tested as a mutant genotype (TT) by RFLP assay. The results reveal a MAF value of 0.3 for this gene in Iraqi samples, more than Europeans (0.2) and less than East Asians (0.55). The codominant model had significant OR of both alleles CT and TT (OR=4.26 & 6.7; P-value=0.012 & 0.023 respectively). In conclusion, there is an association between increased severity of SARS-Cov-2 infection and rs2285666 polymorphism of the codominant genotype model of the Iraqi population. However, several other factors may affect disease severity, such as ethnic group differences, sex, comorbidity, virus strain, and others.
Identifiants
pubmed: 37312742
doi: 10.22092/ARI.2022.358871.2323
pii: ARI-78-1
pmc: PMC10258288
doi:
Substances chimiques
Angiotensin-Converting Enzyme 2
EC 3.4.17.23
ACE2 protein, human
EC 3.4.17.23
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9-14Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.
Références
Commun Biol. 2021 Apr 12;4(1):475
pubmed: 33846513
Cell Discov. 2020 Feb 24;6:11
pubmed: 32133153
Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759
pubmed: 32663409
J Immunol. 2014 Sep 15;193(6):3080-9
pubmed: 25135833
Intensive Care Med. 2020 Apr;46(4):586-590
pubmed: 32125455
J Virol. 2020 Mar 17;94(7):
pubmed: 31996437
Nature. 2005 Jul 7;436(7047):112-6
pubmed: 16001071
Front Physiol. 2012 Sep 12;3:364
pubmed: 22988445
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Sci China Life Sci. 2020 Mar;63(3):457-460
pubmed: 32009228
Eur Rev Med Pharmacol Sci. 2013 Oct;17(19):2654-9
pubmed: 24142614
Nat Med. 2005 Aug;11(8):875-9
pubmed: 16007097
Aging (Albany NY). 2020 Jun 5;12(11):10087-10098
pubmed: 32501810
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Genes (Basel). 2020 Jul 03;11(7):
pubmed: 32635188
Mol Biol Rep. 2020 Jun;47(6):4383-4392
pubmed: 32410141
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Vascul Pharmacol. 2020 Jul;130:106680
pubmed: 32423553
Cell. 2020 May 14;181(4):905-913.e7
pubmed: 32333836
Eur J Intern Med. 2020 Jun;76:14-20
pubmed: 32336612
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Comp Med. 2007 Oct;57(5):450-9
pubmed: 17974127